EUVIMEDEUVIMED entdecken
Open Access

Efficacy of rifapentine and other rifamycins against Coxiella burnetii in vitro

Halie K Miller iD, Gilbert J Kersh iD

Microbiology Spectrum · 2024

DOI: 10.1128/spectrum.01034-24 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbiology Spectrum, 2024. Verfasst von Halie K Miller und 1 weiteren Autor:innen. Beteiligte Einrichtung: Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA. Hauptthemen laut MEDLINE: Rifampin, Microbial Sensitivity Tests, Anti-Bacterial Agents, Coxiella burnetii. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Since 1999, doxycycline and hydroxychloroquine have been the recommended treatment for chronic Q fever, a life-threatening disease caused by the bacterial pathogen, Coxiella burnetii . Despite the duration of its use, the treatment is not ideal due to the lengthy treatment time, high mortality rate, resistant strains, and the potential for contraindicated usage. A literature search was conducted to identify studies that screened large panels of drugs against C. burnetii to identify novel targets with potential efficacy against C. burnetii . Twelve candidate antimicrobials approved for use in humans by the US Food and Drug Administration were selected and minimum inhibitory concentrations (MICs) were determined against the low virulence strain Nine Mile phase II. Rifabutin and rifaximin were the best performing antibiotics tested with MICs of ≤0.01 µg mL −1 . Further screening of these top candidates was conducted alongside two drugs from the same class, rifampin, well-characterized , and rifapentine, not previously reported against C. burnetii . These were screened against virulent strains of C. burnetii representing three clinically relevant genotypes. Rifapentine was the most effective in the human monocytic leukemia cell line, THP-1, with a MIC ≤0.01 µg mL −1 . In the human kidney epithelial cell line, A-498, efficacy of rifapentine, rifampin, and rifabutin varied across C. burnetii strains with MICs between ≤0.001 and 0.01 µg mL −1 . Rifampin, rifabutin, and rifapentine were all bactericidal against C. burnetii ; however, rifabutin and rifapentine demonstrated impressive bactericidal activity as low as 0.1 µg mL −1 and should be further explored as alternative Q fever treatments given their efficacy in vitro . IMPORTANCE This work will help inform investigators and physicians about potential alternative antimicrobial therapies targeting the causative agent of Q fever, Coxiella burnetii . Chronic Q fever is difficult to treat, and alternative antimicrobials are needed. This manuscript explores the efficacy of rifamycin antibiotics against virulent strains of C. burnetii representing three clinically relevant genotypes in vitro . Importantly, this study determines the susceptibility of C. burnetii to rifapentine, which has not been previously reported. Evaluation of the bactericidal activity of the rifamycins reveals that rifabutin and rifapentine are bactericidal at low concentrations, which is unusual for antibiotics against C. burnetii .

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RifampinMicrobial Sensitivity TestsAnti-Bacterial AgentsCoxiella burnetiiRifamycinsQ FeverHumansRifabutinCell Line

Stichwörter der Autor:innen

Q feverantibioticsantimicrobial activitybacterial infectionbactericidal activityzoonotic infections

Substanzen

RifampinAnti-Bacterial AgentsrifapentineRifamycinsRifabutin

Autor:innen und Institutionen

  • Rickettsial Zoonoses Branch, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.

ORCID-Profile: Halie K Miller, Gilbert J Kersh

Zitieren

APA

Miller, H. K., & Kersh, G. J. (2024). Efficacy of rifapentine and other rifamycins against Coxiella burnetii in vitro. Microbiology Spectrum. https://doi.org/10.1128/spectrum.01034-24

Vancouver

Miller HK, Kersh GJ. Efficacy of rifapentine and other rifamycins against Coxiella burnetii in vitro. Microbiology Spectrum. 2024. doi:10.1128/spectrum.01034-24

BibTeX
@article{Miller2024,
  author = {Miller, Halie K and Kersh, Gilbert J},
  title = {Efficacy of rifapentine and other rifamycins against Coxiella burnetii in vitro},
  journal = {Microbiology Spectrum},
  year = {2024},
  doi = {10.1128/spectrum.01034-24}
}
Kostenlos starten →